Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · IEX Real-Time Price · USD
44.43
+1.06 (2.44%)
At close: Mar 27, 2024, 4:00 PM
44.51
+0.08 (0.18%)
After-hours: Mar 27, 2024, 7:27 PM EDT

Crinetics Pharmaceuticals Stock Forecast

Stock Price Forecast

The 12 analysts with 12-month price forecasts for CRNX stock have an average target of 56.25, with a low estimate of 35 and a high estimate of 80. The average target predicts an increase of 26.60% from the current stock price of 44.43.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $35 $56.25 $56 $80
Change -21.22% +26.60% +26.04% +80.06%

Analyst Ratings

The average analyst rating for CRNX stock from 12 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Oct '23Nov '23Dec '23Jan '24Feb '24Mar '24
Strong Buy 111113
Buy 678999
Hold 000000
Sell 000000
Strong Sell 000000
Total 789101012

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Oppenheimer
Oppenheimer
Buy
Maintains
$54$55
Buy Maintains $54$55 +23.79% Mar 20, 2024
JMP Securities
JMP Securities
Buy
Maintains
$60$80
Buy Maintains $60$80 +80.06% Mar 20, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$50$60
Strong Buy Maintains $50$60 +35.04% Mar 20, 2024
JonesTrading
JonesTrading
Strong Buy
Maintains
$52$56
Strong Buy Maintains $52$56 +26.04% Mar 20, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$50
Strong Buy Reiterates $50 +12.54% Mar 19, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
11.14M
from 4.01M
Increased by 177.55%
Revenue Next Year
40.25M
from 11.14M
Increased by 261.38%
EPS This Year
-3.35
from -3.69
EPS Next Year
-3.73
from -3.35
Year 2019202020212022202320242025202620272028
Revenue
1.19M71.00K1.08M4.74M4.01M11.14M40.25M127.14M445.47M910.28M
Revenue Growth
-50.86%-94.05%1,418.31%339.42%-15.28%177.55%261.38%215.88%250.38%104.34%
EPS
-2.09-2.42-2.80-3.15-3.69-3.35-3.73-3.161.114.34
EPS Growth
---------289.91%
No. Analysts -----1414955
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 107.1M 195.4M 485.9M 895.3M 1.4B
Avg 11.1M 40.3M 127.1M 445.5M 910.3M
Low n/a 2.9M 23.7M 171.5M 239.1M

Revenue Growth

Revenue Growth 20242025202620272028
High
2,568.8%
1,654.3%
1,107.3%
604.2%
219.4%
Avg
177.5%
261.4%
215.9%
250.4%
104.3%
Low -
-73.6%
-41.1%
34.9%
-46.3%

EPS Forecast

EPS 20242025202620272028
High -2.66 -3.08 1.79 5.90 10.65
Avg -3.35 -3.73 -3.16 1.11 4.34
Low -3.75 -4.76 -4.84 -2.24 -1.70

EPS Growth

EPS Growth 20242025202620272028
High - - - -
857.6%
Avg - - - -
289.9%
Low - - - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.